EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MetALD: Terminology, Implications, and Therapeutic Considerations

Eda Kaya, Mohamad Amer Nashtar, Henriette Kreimeyer, Ali Canbay iD

Zeitschrift für Gastroenterologie · 01.09.2026 · 64 (09) · 1281-1290

DOI: 10.1055/a-2922-7499 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.09.2026. Verfasst von Eda Kaya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ruhr University Bochum, Department of Medicine, Knappschaft Kliniken University Hospital Bochum, NRW, Germany, Bochum. Hauptthemen laut MEDLINE: Terminology as Topic, Fatty Liver, Alcohol Drinking. Die Arbeit nennt 67 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the introduction of steatotic liver disease (SLD) as an umbrella term and metabolic dysfunction-associated steatotic liver disease (MASLD) as one of its major subcategories, a new diagnostic category was proposed to better reflect the coexistence of metabolic dysfunction and alcohol consumption: MetALD. MetALD identifies individuals with hepatic steatosis and cardiometabolic risk factors whose alcohol intake exceeds MASLD thresholds but remains below the levels typical of alcohol-related liver disease. The prevalence of MetALD in the general population is approximately 4%. Evidence suggests that MetALD is associated with more severe liver-related outcomes and higher all-cause mortality compared to MASLD, although findings are not entirely consistent. Despite these risks, MetALD remains underdiagnosed because alcohol consumption is often self-reported and underestimated due to recall bias, social desirability bias, or stigma. Consequently, managing MetALD requires a multidisciplinary approach addressing both cardiometabolic comorbidities and alcohol-related behavioral factors. MetALD should be viewed not only as a medical condition but also as a disorder with significant behavioral and social dimensions that influence diagnosis, treatment adherence, and long-term outcomes. This review discusses the clinical implications and therapeutic considerations specific to this newly introduced terminology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Terminology as TopicFatty LiverAlcohol DrinkingHumansRisk FactorsComorbidityEvidence-Based Medicine

Autor:innen und Institutionen

  • Ruhr University Bochum, Department of Medicine, Knappschaft Kliniken University Hospital Bochum, NRW, Germany, Bochum.

ORCID-Profile: Ali Canbay

Zitieren

APA

Kaya, E., Nashtar, M. A., Kreimeyer, H., & Canbay, A. (2026). MetALD: Terminology, Implications, and Therapeutic Considerations. Zeitschrift für Gastroenterologie, 64(09), 1281-1290. https://doi.org/10.1055/a-2922-7499

Vancouver

Kaya E, Nashtar MA, Kreimeyer H, Canbay A. MetALD: Terminology, Implications, and Therapeutic Considerations. Zeitschrift für Gastroenterologie. 2026;64(09):1281-1290. doi:10.1055/a-2922-7499

BibTeX
@article{Kaya2026,
  author = {Kaya, Eda and Nashtar, Mohamad Amer and Kreimeyer, Henriette and Canbay, Ali},
  title = {MetALD: Terminology, Implications, and Therapeutic Considerations},
  journal = {Zeitschrift für Gastroenterologie},
  year = {2026},
  volume = {64},
  number = {09},
  pages = {1281--1290},
  doi = {10.1055/a-2922-7499}
}
Kostenlos starten →